What is MIGS Glaucoma Treatment?
Glaucoma affects 2.7 million people in the United States, a number that is expected to grow to 6.3 million by 2050. The most common type of glaucoma-called Primary Open Angle Glaucoma is typically treated with eye drops or an in office laser treatment as the first option. In the past, if the disease progressed to moderate or advanced stage or wasn’t well controlled, ophthalmologists would perform an invasive surgical procedure called Trabeculectomy. Today, we are fortunate to have options called Minimally Invasive Glaucoma Surgery, or MIGS which offers a new option for patients with mild to moderate glaucoma, filling a gap between medication and more invasive Trabeculectomy procedures. MIGS is less invasive with quicker recovery times, has fewer complications and is also safer than Trabeculectomy.
If you or someone you know is over 40, or has other glaucoma risk factors such as family history or being of African-American or Hispanic heritage, please be sure to have annual eye exams with glaucoma testing as glaucoma vision loss can be prevented with early detection and treatment. Schedule an eye exam at Ridgewood Eye Associates at 201-857-4999, visit Ridgewood Eye Associates or Facebook.
Ridgewood Eye Associates is a comprehensive eye care practice staffed by NJ ophthalmologist eye doctors and eye specialists located 1 W. Ridgewood Avenue, Suite 101, Paramus, New Jersey 07652, 201-857-4999, an affiliate of Prism Vision Group.